US2011212885A1PendingUtilityA1
Ophthalmic and contact lens solutions containing peptides as preservative
Individually held — no corporate assignee on recordPriority: Apr 15, 2003Filed: Mar 1, 2011Published: Sep 1, 2011
Est. expiryApr 15, 2023(expired)· nominal 20-yr term from priority
A61L 12/142A61K 38/1709A61P 31/00A61P 27/02C11D 3/0078C11D 3/38C11D 3/48A61K 38/10
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method and a contact lens solution comprising 0.001 to 10 weight percent or a preservative enhancer chosen from the group consisting of: SEQ ID NO.1 and SEQ ID NO. 2; and at least 0.0001 weight percent of a preservative agent, and where the concentration of chloride in said solution is less than 0.2 percent by weight.
Claims
exact text as granted — not AI-modified1 . An ophthalmic solution comprising 0.001 to 10 weight percent of a peptide chosen from the group consisting of SEQ ID NO.1 and SEQ ID NO. 2; and at least 0.0001 weight percent of a preservative agent, and where the concentration of chloride in said solution is less than 0.2 percent by weight.
2 . The solution of claim 1 , wherein said preservative agent is a cationic polymeric preservative having a concentration between 1 and 100 parts per million.
3 . The solution of claim 1 , further comprising a physiologically compatible buffer selected from the group consisting of phosphate, bicarbonate, citrate, borate, ACES, BES, BICINE, BIS, BIS-Tris, BIS-Tris Propane, HEPES, HEPPS, imidazole, Tris, MES, MOPS, PIPES, TAPS, TES, Glycine and Tricine.
4 . The solution of claim 1 , further comprising between 0.01% and 5.0% glycerin.
5 . The solution of claim 1 further comprising between 0.01% and 2.0% of decanedioic acid.
6 . The solution of claim 1 further comprising a wetting agent selected from the group consisting of polysorbate surfactants, polyoxyethylene surfactants, phosphonates, saponins and polyethoxylated castor oils.
7 . The solution of claim 1 further comprising a sequestering agent selected from the group consisting as ethylenediaminetetraacetic acid, phosphonates, citrate, gluconate and tartarate.
8 . The solution of claim 1 , wherein the concentration of chloride in said solution is not more than 0.2 mole percent.
9 . The solution of claim 1 , wherein said solution has a pH between 6.0 and 8.0.
10 . The solution of claim 2 , wherein said cationic polymeric preservative is polyhexamethylene biguanide.
11 . A method for wetting a contact lens comprising the steps of:
providing a contact lens; and contacting said contact lens with a solution comprising 0.001 to 10 weight percent of peptide chosen from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2; and at least 0.0001 weight percent of a preservative agent, and where the concentration of chloride in said solution not more than 0.2 percent by weight.
12 . The method of claim 11 , wherein said preservative agent is a cationic polymeric preservative having a concentration between 1 and 100 parts per million.
13 . The method of claim 12 , wherein said cationic polymeric preservative is polyhexamethylene biguanide.
14 . The method of claim 11 , wherein said solution further comprises a physiologically compatible buffer selected from the group consisting of phosphate, bicarbonate, citrate, borate, ACES, BES, BICINE, BIS, BIS-Tris, BIS-Tris Propane, HEPES, HEPPS, imidazole, Tris, MES, MOPS, PIPES, TAPS, TES, Glycine and Tricine.
15 . The method of claim 11 , wherein said solution has a pH between 6.0 and 8.0.
16 . A method for delivering an ophthalmic solution to the eye comprising the steps of:
providing a bottle comprising a solution comprising 0.001 to 10 weight percent of peptide chosen from the group consisting of SEQ ID NO. 1 and SEQ ID NO. 2; and at least 0.0001 weight percent of a preservative agent, and where the concentration of chloride in said solution not more than 0.2 percent by weight; and delivering said solution form said bottle to an eye such that the solution comes in direct contact with corneal tissue.
17 . The method of claim 16 , wherein said preservative agent is a cationic polymeric preservative having a concentration between 1 and 100 parts per million.
18 . The method of claim 17 , wherein said cationic polymeric preservative is polyhexamethylene biguanide.
19 . The method of claim 16 , wherein said solution further comprises a physiologically compatible buffer selected from the group consisting of phosphate, bicarbonate, citrate, borate, ACES, BES, BICINE, BIS, BIS-Tris, BIS-Tris Propane, HEPES, HEPPS, imidazole, Tris, MES, MOPS, PIPES, TAPS, TES, Glycine and Tricine.
20 . The method of claim 16 , wherein said solution has a pH between 6.0 and 8.0.Join the waitlist — get patent alerts
Track US2011212885A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.